GWP
ZBH icon

Gen-Wealth Partners’s Zimmer Biomet ZBH Stock Holding History

Gen-Wealth Partners’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$40.2K Buy
445
+99
+29% +$9.09K 0.01% 415
2025
Q4 		$31.1K Buy
+346
New +$32.8K 0.01% 429

Other funds holding ZBH

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Gen-Wealth Partners's ZBH Position: Q1 2026 in Review

Gen-Wealth Partners increased its Zimmer Biomet (ZBH) stake by 29% in Q1 2026, buying an estimated $9.09K and bringing the position to 445 shares worth $40.2K. The position accounts for 0.01% of the portfolio, ranked #415.

Gen-Wealth Partners first reported a position in ZBH in Q4 2025 and has held it in 2 quarters since. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

  • Gen-Wealth Partners held 445 shares of Zimmer Biomet worth $40.2K as of Q1 2026.
  • Gen-Wealth Partners bought 99 Zimmer Biomet shares in Q1 2026, an estimated $9.09K.
  • Zimmer Biomet made up 0.01% of Gen-Wealth Partners's portfolio in Q1 2026, its #415 holding.
  • Gen-Wealth Partners first reported a position in Zimmer Biomet in Q4 2025 and has held it in 2 quarters since.
  • 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on Gen-Wealth Partners's 13F filing for Q1 2026, filed 8 May 2026.